Anti–IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone lossYu‐Hsiang Hsu(National Cheng Kung University), Ming-Shi Chang(Institute of Physiology and Basic Medicine)The Journal of Experimental MedicineAugust 15, 201110.1084/jem.20102234Cited by 88SaveCiteExport RISWatch citationsRelated PapersIL-20 Is Regulated by Hypoxia-Inducible Factor and Up-Regulated after Experimental Ischemic Stroke|The Journal of Immunology|2009|78Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis|PLoS ONE|2017|27IL‐20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation|Immunology|2021|27